Key information made simple
What is this study testing?
This study is testing whether a blood test or biomarker may be useful for adults experiencing schizophrenia.
What would participation involve?
Participants may complete a blood test or biomarker, complete questionnaires or follow-up assessments, take part in interviews. The registry lists locations in Germany, in Greece, and in the Netherlands.
Who is it mainly for?
This study appears to be mainly for adults with schizophrenia.
What should you check before joining?
Ask about whether there is a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.

